Breast Imaging: Page 66

DBT bests CBCT for identifying noncalcified breast lesions
By Kate Madden Yee
Wednesday, November 28 | 3:40 p.m.-3:50 p.m. | SSM01-05 | Arie Crown TheaterDigital breast tomosynthesis (DBT) is better for identifying noncalcified breast lesions, both malignant and benign, than noncontrast conebeam CT (CBCT), and readers are more confident using tomosynthesis to characterize lesions, according to Pennsylvania researchers.
November 13, 2012
CAD may improve breast ultrasound specificity
By Erik L. Ridley
Wednesday, November 28 | 3:00 p.m.-3:10 p.m. | SSM01-01 | Arie Crown TheaterThis scientific session will describe how a computer-aided detection (CAD) scheme can help distinguish between benign and malignant masses on breast ultrasound exams.
November 13, 2012
Combining DBT with FFDM almost doubles reading time
By Kate Madden Yee
Wednesday, November 28 | 10:40 a.m.-10:50 a.m. | VSBR41-11 | Arie Crown TheaterAdding digital breast tomosynthesis (DBT) to full-field digital mammography (FFDM) almost doubles interpretation time for all breast densities compared with FFDM alone -- with the exception of extremely dense breast tissue, Yale University researchers have found.
November 13, 2012
Breast cancer screening with DBT reduces cost, lowers dose
By Kate Madden Yee
Wednesday, November 28 | 10:20 a.m.-10:30 a.m. | VSBR41-09 | Arie Crown TheaterBreast cancer screening with digital breast tomosynthesis (DBT) may reduce cost, lower radiation dose, and improve workflow in the diagnostic breast imaging environment, according to researchers from Yale University.
November 13, 2012
Confusion about breast MRI affects mammography adherence
By Kate Madden Yee
Tuesday, November 27 | 5:00 p.m.-5:30 p.m. | LL-BRS-TU2C | Lakeside Learning CenterScreening MRI may negatively affect annual mammography screening, which makes it crucial to teach women that MRI is an adjunct to -- not a replacement for -- annual mammograms, say researchers from Commonwealth Medical College.
November 13, 2012
'White wall' characteristic on ABUS indicates benign lesion
By Kate Madden Yee
Tuesday, November 27 | 3:40 p.m.-3:50 p.m. | SSJ01-05 | Arie Crown TheaterAn echogenic "white wall" in a hypoechoic lesion visualized on automated breast ultrasound (ABUS) suggests a benign lesion, and patients may not need to be recalled for further evaluation, according to researchers from George Washington University Medical Center.
November 13, 2012
ABUS boosts mammography's performance
By Kate Madden Yee
Tuesday, November 27 | 3:30 p.m.-3:40 p.m. | SSJ01-04 | Arie Crown TheaterWhat does automated breast ultrasound (ABUS) contribute to cancer screening when it's used with mammography in women with dense breasts? Researchers from the University of Chicago will present findings that address this question on Tuesday afternoon.
November 13, 2012
ABUS detects suspicious lesions found on breast MRI
By Kate Madden Yee
Tuesday, November 27 | 3:00 p.m.-3:10 p.m. | SSJ01-01 | Arie Crown TheaterAutomated breast ultrasound (ABUS) could prove helpful for evaluating additional suspicious lesions identified by breast MRI, and it's faster and more cost-effective than handheld second-look ultrasound, according to a study that will be presented on Tuesday afternoon.
November 13, 2012
Breast MRI tumor features may predict cancer recurrence
By Kate Madden Yee
Tuesday, November 27 | 11:20 a.m.-11:30 a.m. | SSG01-06 | Arie Crown TheaterBreast MRI tumor-specific interpretation features may have value in assessing breast cancer prognosis and aid in treatment decisions, University of Pennsylvania researchers will report in this Tuesday morning session.
November 13, 2012
Adding DBT to mammography lowers recall rates
By Kate Madden Yee
Monday, November 26 | 3:30 p.m.-3:40 p.m. | SSE02-04 | Room E450AUsing digital breast tomosynthesis (DBT) as an adjunct to mammography lowers recall rates, according to this Monday afternoon scientific session.
November 13, 2012
DBT plus mammography equals increased cancer detection
By Kate Madden Yee
Monday, November 26 | 3:10 p.m.-3:20 p.m. | SSE02-02 | Room E450AAdding digital breast tomosynthesis (DBT) to mammography can increase the cancer detection rate from 1.5% to 2.3%, researchers from Spain have concluded.
November 13, 2012
DBT reduces callbacks, boosts cancer detection
By Kate Madden Yee
Monday, November 26 | 12:45 p.m.-1:15 p.m. | LL-BRS-MO8B | Lakeside Learning CenterThe first five months of using digital breast tomosynthesis (DBT) in a screening practice showed a small reduction in the overall callback rate and a small increase in the cancer detection rate; however, these results were not statistically significant, according to researchers from the University of Pennsylvania.
November 13, 2012
Previous Page
Page 66 of 87
Next Page